TraceVida (Health)

Project Overview

• TraceVida (formerly MediTrace)

• Industry: Pharmaceutical supply chain, public health

• Project Name: TraceVida

• Geographic Reach: Latin America (initial rollout in Peru)

• BSV Integration Start Date: 2025

• Project status: Development phase transitioning to pilot testing (as of Sep 2025)

Business Challenge

Existing Inefficiencies or Risks:

• In March 2025, a contaminated saline solution from Medifarma S.A. with 600% excess sodium caused at least 7 deaths across Peru.

• Regulatory agencies failed to trace ~4,000 bottles after a belated recall attempt.

• Only 33% of Peru’s pharmaceutical sector complies with Good Manufacturing Practices.

• 1 in 10 medicines in emerging markets are substandard or falsified (WHO).

Why Traditional Systems Were Insufficient:

• Lack of end-to-end traceability across fragmented supply chains.

• Inability to provide real-time product verification to patients and pharmacies.

• Costly or centralized systems inaccessible to lower-income markets.

What Made BSV Ideal:

• Microtransactions: Verification costs just $0.001 thanks to BSV’s network fee of ~$0.0000005.

• Sub-second transaction speed enables real-time scanning and validation.

• On-chain immutability provides tamper-proof records for compliance and auditing.

• BSV’s unbounded scaling accommodates millions of verifications per day.

Comparison to Other Blockchain Options:

• Ethereum-based systems like PharmaChain 3.0 have average transaction costs of $0.86 and latency of 16–25 seconds.

• TraceVida offers 99.9% cost reduction and significantly faster throughput compared to Ethereum and NEM-based models.

Solution Architecture

Overview:

• TraceVida assigns every medicine batch a unique blockchain ID embedded in a scannable QR code.

• End-to-end traceability is achieved from manufacturer to patient, recording each supply chain touchpoint.

Key Components:

• QR Code Generation: Encodes BSV transaction ID for each product batch.

• Real-Time Updates: Each supply chain event is immutably logged on-chain.

• Instant Verification: Patients and pharmacies verify product authenticity at point-of-care.

• Smart Contracts (future-ready): Legal and compliance frameworks embedded in token logic.

Integration Partners:

• Designed to integrate with 407 regulatory and pharmaceutical databases across Latin America.

Implementation Process

Phases of Rollout:

• Initial development and pilot phase in Peru.

• Leverages momentum from the regulatory reform (closure of DIGEMID and formation of APEMED post-Medifarma crisis).

Integration with Legacy Systems:

• Designed to interoperate with Peru’s drug authority review framework (e.g., 45-day Category 1 review timeline).

• Standardized data formats to accommodate cross-country regulatory differences.

Stakeholder Onboarding:

• Consortium-based governance including pharma companies, regulators, hospitals, and distributors.

• No upfront costs; $0.001 pay-per-verification lowers entry barriers for widespread adoption.

Outcomes & Business Impact

Quantifiable Improvements:

• 99.9% reduction in verification costs compared to Ethereum systems.

• Potential prevention of mass casualty events like the Medifarma crisis.

• Transparent, decentralized tracking system promotes trust among patients and providers.

Before vs After:

• Before: Centralized traceability failures, delayed recalls, opaque regulatory frameworks.

• After: Verifiable medicine at point-of-care for less than a cent per scan, with real-time tracking and immutable auditing.

Stakeholder Feedback:

• “Making every medicine verifiable, every life protected.” — TraceVida slogan.

• Positive response from regulatory reformers and healthcare advocates seeking low-cost safety tools.

Challenges & Mitigations

Key Challenges:

• Regulatory fragmentation across Latin American countries.

• General mistrust among data stakeholders (hospitals, ministries, suppliers).

How BSV Helped Overcome Them:

• Blockchain’s transparency and immutability addressed trust and accountability gaps.

• Open integration architecture accommodates data heterogeneity across 407 regional databases.

Future Vision

Expansion Plans:

• Scale TraceVida across Latin America and adapt for other public health tracking use cases (e.g., vaccines, temperature-sensitive logistics).

Additional BSV Capabilities to Be Explored:

• Smart contracts for embedded compliance.

• Real-time alerts for cold-chain violations.

• Incentive systems via satoshi micropayments for pharmacy adoption and data validation.